These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7673654

  • 1. Trazodone treatment increases plasma prolactin concentrations in depressed patients.
    Otani K, Yasui N, Kaneko S, Ishida M, Ohkubo T, Osanai T, Sugawara K, Fukushima Y.
    Int Clin Psychopharmacol; 1995 Jun; 10(2):115-7. PubMed ID: 7673654
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Ishida M, Otani K, Kaneko S, Ohkubo T, Osanai T, Yasui N, Mihara K, Higuchi H, Sugawara K.
    Int Clin Psychopharmacol; 1995 Sep; 10(3):143-6. PubMed ID: 8675966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical correlates of antidepressant response. Results of a trazodone versus amitriptyline trial.
    Healy D, Carney PA, Leonard BE.
    Psychopathology; 1984 Sep; 17 Suppl 2():82-7. PubMed ID: 6326178
    [Abstract] [Full Text] [Related]

  • 11. Effects of genetic polymorphism of CYP1A2 inducibility on the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine in depressed Japanese patients.
    Mihara K, Kondo T, Suzuki A, Yasui-Furukori N, Ono S, Otani K, Kaneko S.
    Pharmacol Toxicol; 2001 May; 88(5):267-70. PubMed ID: 11393588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression.
    Otani K, Yasui N, Kaneko S, Ohkubo T, Osanai T, Sugawara K.
    Int Clin Psychopharmacol; 1996 Mar; 11(1):55-7. PubMed ID: 8732315
    [Abstract] [Full Text] [Related]

  • 15. Plasma trazodone concentrations and clinical response in elderly depressed patients: a preliminary study.
    Monteleone P, Gnocchi G, Delrio G.
    J Clin Psychopharmacol; 1989 Aug; 9(4):284-7. PubMed ID: 2768543
    [Abstract] [Full Text] [Related]

  • 16. Trazodone in endogenous depressed patients: a negative report and a critical evaluation of the pertaining literature.
    Klein HE, Müller N.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Aug; 9(2):173-86. PubMed ID: 4001432
    [Abstract] [Full Text] [Related]

  • 17. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.
    Otani K, Tybring G, Mihara K, Yasui N, Kaneko S, Ohkubo T, Nagasaki T, Sugawara K.
    Eur J Clin Pharmacol; 1998 Jan; 53(5):347-9. PubMed ID: 9516035
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of dosage and route of administration of trazodone on cerebral concentration of 1-m-chlorophenylpiperazine in rats. Kinetics of trazodone biotransformation in rats.
    Rurak A, Melzacka M.
    Pol J Pharmacol Pharm; 1983 Jan; 35(3):241-7. PubMed ID: 6622303
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.